Has Ilia Zeltser, MD received payments from drug or device companies?

Yes. Drug and device makers reported $89,507 in general payments to Ilia Zeltser, MD across 395 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ilia Zeltser, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ilia Zeltser, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ilia Zeltser, MD

Urology · Bryn Mawr, PANPI 1689689473

Payments from drug & device makers

$89,507in general payments, 2019–2025

Across 395 payments — averaging $226.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$55K
Pfizer$9K
Myovant Sciences Inc.$9K
Astellas Pharma US Inc$5K
Dendreon Pharmaceuticals LLC$2K
AstraZeneca$2K
plus $6K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	88	$55,191
Pfizer	34	$9,318
Myovant Sciences Inc.	14	$8,967
Astellas Pharma US Inc	46	$5,107
Dendreon Pharmaceuticals LLC	19	$2,433
AstraZeneca	28	$2,311
Janssen Scientific Affairs, LLC	2	$1,908
Merck	19	$478
Bayer	18	$403
KARL Storz Endoscopy-america	13	$345
Ferring Pharmaceuticals Inc.	12	$328
Urogen Pharma, Inc.	8	$234
Immunitybio, Inc.	6	$219
Medtronic(2 entities)	5	$216
AbbVie(2 entities)	9	$170
Boston Scientific	7	$147
Bioprotect Medical, Inc.	2	$144
Progenics Pharmaceuticals, Inc.	5	$144
Telix Pharmaceuticals	7	$141
Novartis	7	$134
Teleflex LLC	1	$127
Davol Inc.	2	$124
Paratek Pharmaceuticals, Inc.	1	$123
Smith+Nephew	4	$97
Amgen	5	$97
Tolmar Pharmaceuticals, Inc.	3	$65
Photocure Inc	4	$59
Accord Healthcare, Inc.	3	$59
Mimedx Group, Inc.	3	$57
Baxter Healthcare	2	$53
Eisai Inc.	2	$40
Tolmar, Inc.	2	$37
Beigene USA, Inc.	1	$27
Sun Pharmaceutical Industries Inc.	1	$24
Coloplast	1	$23
Clinigen, Inc.	1	$21
Conmed Corporation	1	$18
Mirati Therapeutics, Inc.	1	$18
Laborie Medical Technologies Corp.	2	$16
Clovis Oncology, Inc.	1	$15
C. R. Bard, Inc. & Subsidiaries	1	$15
Seagen Inc.	1	$14
SRS Medical Systems, Inc.	1	$14
Morphosys, US Inc.	1	$13
Procept Biorobotics Corporation	1	$13

How this compares

$89,507 in reported general payments places this provider in the 90th percentile of 596 urology providers in Pennsylvania.

See all urology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$458,887

Medicare patients

980

Services billed

8,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Bryn Mawr

Guy BernsteinBryn Mawr$41K
Laurence BelkoffBala Cynwyd$18.7M
Paul SieberLancaster$12.6M
Costas LallasPhiladelphia$3.6M
John AndersonBethlehem$2.1M
Jodi MaranchiePittsburgh$1.2M
Kenneth LessansLancaster$943K
Stanley MalkowiczPhiladelphia$882K
Demetrius BagleyPhiladelphia$739K
Gregory TasianPhiladelphia$645K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →